|
Oligos Etc
sequence based reagents (dna oligos) Sequence Based Reagents (Dna Oligos), supplied by Oligos Etc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sequence based reagents (dna oligos)/product/Oligos Etc Average 90 stars, based on 1 article reviews
sequence based reagents (dna oligos) - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
GenScript corporation
5′ utr sequences 5′ Utr Sequences, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/5′ utr sequences/product/GenScript corporation Average 90 stars, based on 1 article reviews
5′ utr sequences - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Oligos Etc
sequence-based reagent (oligos used to clone 5'utr of interest) iqgap1 Sequence Based Reagent (Oligos Used To Clone 5'utr Of Interest) Iqgap1, supplied by Oligos Etc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/sequence-based reagent (oligos used to clone 5'utr of interest) iqgap1/product/Oligos Etc Average 90 stars, based on 1 article reviews
sequence-based reagent (oligos used to clone 5'utr of interest) iqgap1 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Fasmac Co Ltd
5′ utr sequence 5′ Utr Sequence, supplied by Fasmac Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/5′ utr sequence/product/Fasmac Co Ltd Average 90 stars, based on 1 article reviews
5′ utr sequence - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Medicago
2s albumin 5′utr fragment sequence 2s Albumin 5′Utr Fragment Sequence, supplied by Medicago, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/2s albumin 5′utr fragment sequence/product/Medicago Average 90 stars, based on 1 article reviews
2s albumin 5′utr fragment sequence - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Sangon Biotech
crrnas with fluorescent labeling at the 5′-end Crrnas With Fluorescent Labeling At The 5′ End, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/crrnas with fluorescent labeling at the 5′-end/product/Sangon Biotech Average 90 stars, based on 1 article reviews
crrnas with fluorescent labeling at the 5′-end - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
Image Search Results
Table EV2 . Independent validation of TSS isoforms and their associated translational efficiency in genes Ndufb11 , Ube4b , Nedd8 , and Ssu72 , respectively. Left: Under each gene structure, cumulative reads were shown for the alternative TSSs in the “free” fraction and poly9+ fraction. Green arrows above the gene structure indicate the locations of the reverse PCR primer. Red and blue bars represented sequencing reads mapped within distal and proximal TSSs, respectively; gray bars represented reads mapped outside of the identified TSSs. Right: Agarose gel electrophoresis of amplified products of mRNA 5ʹ ends obtained from non‐ribosomal fraction and polysomal fraction. Positions of the distal TSS isoform and the proximal TSS isoforms are indicated with red and blue arrows, respectively. In the case of gene Ndufb11 , the band below the distal TSS (indicated by a yellow arrow) in the gel image was caused by an alternative splicing event, which removed an 88‐nt region for a minor fraction of transcripts initiating at the distal TSS. L, HyperLadder I; N, non‐ribosomal fraction; P, polysomal fraction. The description of these genes can be found in Journal: Molecular Systems Biology
Article Title: Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals
doi: 10.15252/msb.20166941
Figure Lengend Snippet: Scatter plot showing the bootstrap means ( x ‐axis) and standard deviations ( y ‐axis) for log2‐transformed TE difference between 13,118 TSS isoform pairs in the 4,153 multi‐TSS genes. Dashed purple lines indicated the Benjamini–Hochberg adjusted P ‐value of 0.01, and dashed orange lines indicated the 1.5‐fold divergence. Genes with significant TE divergence (Benjamini–Hochberg adjusted P ‐value < 0.01, TE divergence > 1.5‐fold) are depicted in blue. See also
Article Snippet: Both in vitro and in vivo analyses have demonstrated that different
Techniques: Transformation Assay, Biomarker Discovery, Sequencing, Agarose Gel Electrophoresis, Amplification, Alternative Splicing, In Vivo, Derivative Assay, Luciferase, Activity Assay
Journal: Molecular Systems Biology
Article Title: Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals
doi: 10.15252/msb.20166941
Figure Lengend Snippet: Barplots showing the fraction of alternative TSS isoform pairs with and without significant differential TE. Isoform pairs with certain 5ʹUTR length difference were grouped together. The larger the length difference between the two isoforms, the higher the fraction associated with significant TE divergence. Scatter plot comparing the number of ribosomes per mRNA between shorter 5ʹUTR isoforms ( x ‐axis) and longer 5ʹUTR isoforms ( y ‐axis) from the same genes. Purple and green dots were isoform pairs with significant differential TE biased toward longer and shorter isoforms, respectively.
Article Snippet: Both in vitro and in vivo analyses have demonstrated that different
Techniques:
Journal: Molecular Systems Biology
Article Title: Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals
doi: 10.15252/msb.20166941
Figure Lengend Snippet: Left: Boxplots comparing the log2 TE fold changes between two groups of alternative isoform pairs, one group with at least one uORF present in the isoform‐divergent 5ʹUTR and the other without. Right: The group with uORF was further separated into three subgroups according to the number of uORFs present in the divergent 5ʹUTR. Same as (A)—left, but the sequence feature of interest is the out‐of‐frame uAUGs. Same as (A)—left, but the sequence feature of interest is the in‐frame uAUGs. Same as (A)—left, but the sequence feature of interest is the translated uORFs (i.e. supported by ribosome footprinting) with canonical AUG start codon. Same as (A)—left, but the sequence feature of interest is the translated out‐of‐frame uAUGs (i.e. supported by ribosome footprinting). Same as (A)—left, but the sequence feature of interest is the translated uORFs (i.e. supported by ribosome footprinting) with non‐canonical start codons. Same as (A)—left, but the sequence feature of interest is the translated out‐of‐frame upstream non‐canonical start codons (i.e. supported by ribosome footprinting). Data information: ** P < 0.01, *** P < 0.001; Mann–Whitney U ‐test. Box edges represent quantiles, whiskers represent extreme data points no more than 1.5 times the interquartile range.
Article Snippet: Both in vitro and in vivo analyses have demonstrated that different
Techniques: Sequencing, Footprinting, MANN-WHITNEY
Journal: Molecular Systems Biology
Article Title: Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals
doi: 10.15252/msb.20166941
Figure Lengend Snippet: Boxplots comparing the log2 TE fold changes between three groups of alternative isoform pairs, the first group with 5ʹ cap‐adjacent (50 nt to 5ʹ ends) stable RNA secondary structures (MFE < −30 kcal/mol) present only in long 5ʹUTR isoforms, the second group with 5ʹ cap‐adjacent stable RNA structure present/absent in both isoforms, and the last group with 5ʹ cap‐adjacent stable RNA structure present only in short 5ʹUTR isoforms. Boxplots comparing the log2 TE fold changes between two groups of alternative isoform pairs, one group with stable RNA secondary structures (MFE < −35 kcal/mol in any 50‐nt RNA fragments) present in the downstream divergent 5ʹUTR and the other without. Boxplots comparing the log2 TE fold changes between TOP genes and non‐TOP genes (controls). For TOP genes, the TE fold changes were the ratios between the isoforms with 5ʹ TOP sequences present and isoforms without, and for non‐TOP genes, isoforms were randomly assigned as numerators and denominators. Left: Boxplots comparing the log2 TE fold changes between two groups of alternative isoform pairs, one group with the motif AAUCCC present in divergent 5ʹUTRs and the other without. Right: Luciferase assay comparing the relative TE between reporter genes with five copies of motif AAUCCC, reverse complement of motif AAUCCC, and randomly shuffled sequences in their 5ʹUTRs ( n = 3; mean ± SEM; n.s. P > 0.05). Similar to (D), but the motif is CAAGAU ( n = 3; mean ± SEM; * P < 0.05; Student's t ‐test). Data information: In boxplots, * P < 0.05, ** P < 0.01, *** P < 0.001; Mann–Whitney U ‐test. Box edges represent quantiles, whiskers represent extreme data points no more than 1.5 times the interquartile range.
Article Snippet: Both in vitro and in vivo analyses have demonstrated that different
Techniques: Luciferase, MANN-WHITNEY
Journal: Molecular Systems Biology
Article Title: Pervasive isoform‐specific translational regulation via alternative transcription start sites in mammals
doi: 10.15252/msb.20166941
Figure Lengend Snippet: Same as Fig B, but in addition, we marked the six genes that were tested by luciferase reporter assay (Fig C) and containing unambiguously determined 5ʹUTR sequences (see ). The TE divergence values estimated based on 5ʹ end sequencing data are shown in cyan, and those based on reporter assay are shown in yellow.
Article Snippet: Both in vitro and in vivo analyses have demonstrated that different
Techniques: Luciferase, Reporter Assay, Sequencing